Sattar N, Lee MMY, Kristensen SL et al (2021) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
We believe that teaching patients is key to treatment success, so we work to give them the knowledge they need
For Wegovy autoinjectors, follow the specific Instructions for Use, which typically require a longer hold time until the yellow bar stops moving
Combination blockade of GDF8 and ActA was found to be generally well tolerated in this study, with muscle spasms and mouth ulcerations/aphthous ulcers appearing as the main treatment-related adverse events in the combination groups
Let's examine exactly why semaglutide causes diarrhea, what the research tells us about timing and severity, and most importantly, evidence-based strategies to manage it
Studies have found that people taking semaglutide GLP-1 lose an average of 15% of their starting body weight, while those on liraglutide typically lose around 5% to 10%